drugset / Trial / NCT00806338
An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerance of multiple intravenous (through a vein) doses of trodusquemine (MSI-1436) in obese or overweight, type 2 diabetics.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trodusquemine | Small molecule | 3 mg/m2 | Intravenous |
| Subject | Trodusquemine | Small molecule | 6 mg/m2 | Intravenous |
| Subject | Trodusquemine | Small molecule | 10 mg/m2 | Intravenous |